David Schreiber
Direktor/Vorstandsmitglied bei Agendia, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Laura van't Veer | M | - |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 21 Jahre |
| René Bernards | M | 72 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 21 Jahre |
| Kurt Becker | M | 50 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 12 Jahre |
| Catherine Doherty | F | 61 | 34 Jahre | |
| Patrick Balthrop | M | 67 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 7 Jahre |
| Christoph Waer | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Nadia Harbeck | F | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Christy Garcia | F | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 3 Jahre |
| Laurie Heilmann | F | 68 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 5 Jahre |
| An van Es-Johansson | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| M. William Audeh | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 8 Jahre |
| Gary D. Samuels | M | - | 28 Jahre | |
| Sujatha Chandrasekaran | F | 56 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 2 Jahre |
| Ronald Andrews | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 1 Jahre |
| Scott Mendel | M | 57 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 2 Jahre |
| Mark R. Straley | M | 63 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 9 Jahre |
| Peter Michael Stein | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| Erik Esveld | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
| François Ferré | M | 66 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 5 Jahre |
| Fabrice André | M | - |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Richard Sandberg | M | 80 |
DIANON Systems, Inc.
 DIANON Systems, Inc. Medical/Nursing ServicesHealth Services Dianon Systems, Inc. provides anatomic pathology, genetic, and clinical chemistry testing services. The firm offers services in uropathology, dermatopathology, gastrointestinal pathology, hematopathology, and breast pathology. The company was founded in 1983 and is headquartered in Stratford, CT. | 14 Jahre |
| Kenneth Freeman | M | 73 | 9 Jahre | |
| Kirk Calhoun | M | 80 | 7 Jahre | |
| Kevin Johnson | M | 69 |
DIANON Systems, Inc.
DIANON Systems, Inc. Medical/Nursing ServicesHealth Services Dianon Systems, Inc. provides anatomic pathology, genetic, and clinical chemistry testing services. The firm offers services in uropathology, dermatopathology, gastrointestinal pathology, hematopathology, and breast pathology. The company was founded in 1983 and is headquartered in Stratford, CT. | 7 Jahre |
| James T. Barry | M | 62 |
DIANON Systems, Inc.
DIANON Systems, Inc. Medical/Nursing ServicesHealth Services Dianon Systems, Inc. provides anatomic pathology, genetic, and clinical chemistry testing services. The firm offers services in uropathology, dermatopathology, gastrointestinal pathology, hematopathology, and breast pathology. The company was founded in 1983 and is headquartered in Stratford, CT. | 9 Jahre |
| Grant D. Carlson | M | 56 |
DIANON Systems, Inc.
DIANON Systems, Inc. Medical/Nursing ServicesHealth Services Dianon Systems, Inc. provides anatomic pathology, genetic, and clinical chemistry testing services. The firm offers services in uropathology, dermatopathology, gastrointestinal pathology, hematopathology, and breast pathology. The company was founded in 1983 and is headquartered in Stratford, CT. | 12 Jahre |
| Thomas A. Bologna | M | 76 | 4 Jahre | |
| Leanne M. Kiviharju | F | - | - | |
| Mustapha bin Mohamed | M | 67 |
Northern Illinois University
| 6 Jahre |
| Bruce A. Huebner | M | 73 | 2 Jahre | |
| Bastiaan van der Baan | M | 52 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 11 Jahre |
| David Ludvigson | M | 74 | 13 Jahre | |
| William Larry Respess | M | 85 | - | |
| Richard J. Buyens | M | 67 |
Northern Illinois University
| 6 Jahre |
| Robert Hagemann | M | 67 | 17 Jahre | |
| David Wurzer | M | 65 | 5 Jahre | |
| Sam Chawla | M | 49 | 2 Jahre | |
| Richard van den Broek | M | 57 | 5 Jahre | |
| Michael J. Wilson | M | - |
Northern Illinois University
| 6 Jahre |
| Nolida Azmi | F | - |
Northern Illinois University
| 7 Jahre |
| Mark Bibi | M | 65 |
Unilab Corp.
 Unilab Corp. Medical/Nursing ServicesHealth Services Unilab Corp. owns and operates clinical testing labs. It provides glucose, heart disease, aids, cervical cancer, osteoporosis, multiple myeloma, sexually transmitted diseases, screening, and STDs testing services. The company was founded in 1988 and is headquartered in Tarzana, CA. | 6 Jahre |
| Rod Wilson | M | - | - | |
| Michael Metzger | M | 53 | 3 Jahre | |
| Andrea Redmond | F | 68 |
Northern Illinois University
| 4 Jahre |
| Taza bin Razali Ismail | M | 58 |
Northern Illinois University
| 4 Jahre |
| Jess Jankowski | M | 59 |
Northern Illinois University
| 4 Jahre |
| Nawal Hanafiah | F | 60 |
Northern Illinois University
| 4 Jahre |
| Ron Deady | M | - |
Northern Illinois University
| 4 Jahre |
| Mohammad Kamal bin Omar | M | 70 |
Northern Illinois University
| 4 Jahre |
| Lawrence E. Schreiber | M | 67 |
Northern Illinois University
| 4 Jahre |
| George Cardoza | M | 62 | 15 Jahre | |
| Joan Kramer | F | - |
Northern Illinois University
| 4 Jahre |
| Christine Serwinski | F | - |
Northern Illinois University
| 3 Jahre |
| Kevin Sullivan | M | - |
Northern Illinois University
| 4 Jahre |
| Catherine Lang-Cline | F | - |
Northern Illinois University
| 4 Jahre |
| Julie A. Burke | F | - |
Northern Illinois University
| - |
| Mitchell Izumi | M | - |
Northern Illinois University
| 4 Jahre |
| Arturo Saenz | M | - |
Northern Illinois University
| 4 Jahre |
| Claude Grant | M | - |
Northern Illinois University
| 4 Jahre |
| Joseph J. Hodorowicz | M | - |
Northern Illinois University
| 4 Jahre |
| Dave J. Paredes | M | - |
Northern Illinois University
| 4 Jahre |
| Jack Naudi | M | - |
Northern Illinois University
| 3 Jahre |
| Joseph James Hoess | M | 58 |
Northern Illinois University
| 4 Jahre |
| Karl V. Chalupa | M | 66 |
Northern Illinois University
| 3 Jahre |
| Roger Walleck | M | - |
Northern Illinois University
| 4 Jahre |
| Dave Moenning | M | - |
Northern Illinois University
| 4 Jahre |
| Kwok Wa Ho | M | 62 |
Northern Illinois University
| 4 Jahre |
| Daniel J. Arnold | M | 67 |
Northern Illinois University
| 4 Jahre |
| Kenneth E. Bedno | M | - |
Northern Illinois University
| 4 Jahre |
| Thomas E. Murphy | M | 57 |
Northern Illinois University
| 4 Jahre |
| Joel Basgall | M | - |
Northern Illinois University
| 4 Jahre |
| Brett Brown | M | 59 |
Northern Illinois University
| 4 Jahre |
| Clifford Allen Brown | M | 72 |
Northern Illinois University
| 4 Jahre |
| Anthony Abate | M | 69 |
Northern Illinois University
| 4 Jahre |
| Sheila Talton | F | 71 |
Northern Illinois University
| 4 Jahre |
| David Sveen | M | 67 |
Northern Illinois University
| 4 Jahre |
| William G. Gerber | M | 77 | 2 Jahre | |
| Sophia A. Erskine | F | - |
Northern Illinois University
| 4 Jahre |
| John Ferry | M | - |
Northern Illinois University
| 4 Jahre |
| Quentin Ostrowski | M | - |
Northern Illinois University
| 4 Jahre |
| Charlie Sloan | M | - |
Northern Illinois University
| 4 Jahre |
| David Konrad | M | - |
Northern Illinois University
| 4 Jahre |
| George H. Cook | M | - |
Northern Illinois University
| 2 Jahre |
| David W. Hewson | M | - |
Northern Illinois University
| 4 Jahre |
| Howard Blietz | M | - |
Northern Illinois University
| 4 Jahre |
| Thom Everett | M | - |
Northern Illinois University
| 4 Jahre |
| Eric Wasowicz | M | - |
Northern Illinois University
| 4 Jahre |
| Walt Stubbings | M | - |
Northern Illinois University
| 4 Jahre |
| Linda J. Deering | F | - |
Northern Illinois University
| 4 Jahre |
| Tom Ryan | M | - |
Northern Illinois University
| 4 Jahre |
| Noripah binti Kamso | F | 66 |
Northern Illinois University
| 4 Jahre |
| Manuel J. Montejano | M | - |
Northern Illinois University
| 4 Jahre |
| K. Osadjan | F | - |
Northern Illinois University
| 4 Jahre |
| Brent Brodeski | M | - |
Northern Illinois University
| 4 Jahre |
| Kurt Ellinger | M | - |
Northern Illinois University
| 4 Jahre |
| Carl T. Foster | M | 59 | 3 Jahre | |
| Wes Douglas | M | - |
Northern Illinois University
| 4 Jahre |
| Sieg Buck | M | - |
Northern Illinois University
| 8 Jahre |
| Sean Tan | M | 57 |
Northern Illinois University
| 4 Jahre |
| Dave Hubbard | M | - |
Northern Illinois University
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David Schreiber
- Persönliches Netzwerk
